Last reviewed · How we verify

NCT04071275

Assessing Possible Additive Effects of tDCS and Mirror Therapy Treatments for Phantom Pain

Status unknown NA Last updated 29 August 2019
What this trial tests

NA trial testing transcranial Direct Current Stimulation (tDCS) in Phantom Limb Pain in 60 participants. Status unknown.

Timeline
22 April 2018
Primary endpoint
30 November 2019
30 November 2019

Quick facts

Lead sponsorLoewenstein Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date22 April 2018
Primary completion30 November 2019
Estimated completion30 November 2019
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Loewenstein Hospital

Who can join

18 and older, any sex, with Phantom Limb Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study we will examine assess if treatment with transcranial Direct Current Stimulation (tDCS) improve the analgesic effects of mirror therapy for patients with phantom pain of lower extremity. The study will include 3 arms: only mirror therapy, mirror therapy + sham tDCS, and mirror therapy + active tDCS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transcranial Direct Current Stimulation (tDCS)

Trials testing the same drug.

Other recruiting trials for Phantom Limb Pain

Currently open trials in the same condition.

Other Loewenstein Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04071275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing